ClinicalTrials.Veeva

Menu
I

Institut Jantung Negara | Clinical Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Macitentan
JNJ-67896049
Nitric Oxide
Rocuronium
Milvexian
Thienopyridine
Pradaxa
Tocotrienols
Apixaban
Vitamin K

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 37 total trials

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

This is a prospective, multicenter, open-label, randomized, controlled, parallel Phase 3 study with an open-label single-arm extension period to eval...

Active, not recruiting
Pulmonary Arterial Hypertension
Drug: Macitentan
Other: Standard-of-care

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safety of Abl...

Active, not recruiting
Coronary Artery Disease
Diabetes
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)

Trial sponsors

Boston Scientific logo
Actelion Pharmaceuticals logo
Medtronic logo
Janssen (J&J Innovative Medicine) logo
LifeTech Scientific logo
Abbott logo
B
B
Boehringer Ingelheim logo
Concept Medical logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems